lunes, 2 de noviembre de 2009

European stocks fall, affecting pharmaceutical firms

European shares on Monday played four-week lows, which extended the previous session's losses, for fear that the stock market has rebounded well before the economic recovery.

Shares of banks were among those who suffered major losses.

At 1122 GMT, the FTSEurofirst 300 index of leading firms lost 0.2 percent to 976.2 points after falling to 968.19 points, its lowest level since early October.

On Friday, fell 2.1 percent, the biggest decline for a day in almost four months, as affected by weak data on U.S. consumer confidence.

The index, which so far this year has surged by 17 percent, adds a 51 percent since hitting lows in early March.

At the meeting the banks are among the biggest losers, also pressured by news that the Financial CIT Group Inc., a U.S. lender to thousands of small and medium business, declared bankruptcy on Sunday because the global financial crisis.

Shares in Standard Chartered, Barclays, Societe Generale, Credit Agricole and UBS were among the losers.

"Everyone is anxious and know that the market was accelerated a bit," said Koen De Leus, economist at KBC Securities.

"To change that state of mind we need to see better macroeconomic figures for now, corporate profits may not give more support to the stock market since the days of big companies are gone," he added.

No hay comentarios:

Publicar un comentario